CytomX Therapeutics, Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CytomX Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • CytomX Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -41.3 %, a 413% decline year-over-year.
  • CytomX Therapeutics, Inc. annual Return On Equity for 2023 was 0.84 %, a 99.5% decline from 2022.
  • CytomX Therapeutics, Inc. annual Return On Equity for 2022 was 159 %.
  • CytomX Therapeutics, Inc. annual Return On Equity for 2021 was -275 %, a 78.9% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.